Synthesis and Pharmacological Study of Rho-Kinase Inhibitors: Pharmacomodulations on the Lead Compound Fasudil-Reference-Cited by-同舟云学术

Synthesis and Pharmacological Study of Rho-Kinase Inhibitors: Pharmacomodulations on the Lead Compound Fasudil

Published:2003-04-01 Issue:2 Volume:18 Page:127-138
ISSN:1475-6366
Container-title:Journal of Enzyme Inhibition and Medicinal Chemistry
language:en
Short-container-title:Journal of Enzyme Inhibition and Medicinal Chemistry

Author:

Logé Cédric¹,Siomboing Xavier¹,Wallez Valérie¹,Scalbert Elizabeth²,Bennejean Caroline³,Cario-Tourmaniantz Christelle⁴,Loirand Gervaise⁴,Gressier Bernard⁵,Pacaud Pierre⁴,Luyckx Michel¹

Affiliation:

1. Faculté des Sciences Pharmaceutiques et Biologiques, BP 83 Cedex 59006, Lille, France

2. Institut de Recherches Internationales Servier, 6 place des Pléiades Cedex 92415, Courbevoie, France

3. ADIR, 1 rue Carle Hebert Cedex 92415, Courbevoie, France

4. INSERM, Unité 533, Faculté des Sciences et Techniques de Nantes, 2 rue de la Houssinière, Cedex 3 44322, Nantes, France

5. Laboratoire de Pharmacologie, Faculté de Pharmacie, 1 rue des Louvels Cedex 1 80037, Amiens, France

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/1475636031000093561

Reference34 articles.

1. Binding Mode of the 4-Anilinoquinazoline Class of Protein Kinase Inhibitor: X-ray Crystallographic Studies of 4-Anilinoquinazolines Bound to Cyclin-Dependent Kinase 2 and p38 Kinase

2. Cyclin-Dependent Kinase Inhibitors: Useful Targets in Cell Cycle Regulation

3. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension

4. Ono-Saito, N., Niki, I. and Hidaka, H. (1999)Pharmacol. Ther. 82(2 – 3), 123.

5. A Novel Serine/Threonine Kinase Binding the Ras-related RhoA GTPase Which Translocates the Kinase to Peripheral Membranes

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Rho-associated kinase inhibitor fasudil can replace Y-27632 for use in human pluripotent stem cell research;PLOS ONE;2020-05-12

2. Rho-kinase (ROCK) Inhibitors - A Neuroprotective Therapeutic Paradigm with a Focus on Ocular Utility;Current Medicinal Chemistry;2020-04-29